Remove Chemotherapy Remove Drug Development Remove Medical Schools
article thumbnail

STAT+: Foundation charges cancer patients $83,000 for unproven but promising experimental drug

STAT

Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine. Her husband said he had no regrets.

Vaccines 246
article thumbnail

Leveraging innate cell engagers for lymphoma treatment

European Pharmaceutical Review

As a result, when the patient’s lymphoma relapses after treatment with chemotherapy, BV and CPIs, there are no effective treatment alternatives for these patients. Before joining ImClone, he was the Senior Vice President of the Global Clinical Development Unit, Oncology, at Merck Serono. Dr Harstrick received his M.D.